1,25-Dihydroxyvitamin D3 receptors: altered functional domains are associated with cellular resistance to vitamin D3.

J. W. Pike, E. A. Allegretto, M. A. Kelly, C. A. Donaldson, S. L. Marion, D. J. Mangelsdorf, Mark R Haussler

Research output: Contribution to journalArticle

Abstract

1,25-Dihydroxyvitamin D3 receptors are cytosoluble proteins detectable in a variety of tissues responsive to 1,25(OH)2D3. They are DNA binding-proteins analogous to other steroid receptors and it is this functional property which is likely involved in the activation of hormone-sensitive genes. Utilizing 1,25(OH)2D3 and DNA binding assays, as well as anti-receptor monoclonal antibodies, we have probed the relationship between the 1,25(OH)2D3 receptor binding domains after selective cleavage with trypsin. These studies reveal that the hormone and DNA binding regions are separable, and are consistent with the finding that tissue resistance to 1,25(OH)2D3 is a result of structural defects in these domains. Recently, a primate model, the LLC-MK2 monkey kidney line, has been uncovered which may exemplify a hormone-binding defect. Here, 25-hydroxyvitamin D3-24-hydroxylase induction, a 1,25(OH)2D3 bioresponse, requires 100-fold higher concentrations of the hormone for maximal response. Concomitantly, this cell contains a variant receptor form which displays a correspondingly lowered apparent affinity for the hormone despite its seemingly normal DNA binding characteristics. Taken together, these studies suggest that the 1,25(OH)2D3 receptor is a macromolecule with multiple domains each of which may produce modified cellular resistance to 1,25(OH)2D3 if structurally altered.

Original languageEnglish (US)
Pages (from-to)377-390
Number of pages14
JournalAdvances in Experimental Medicine and Biology
Volume196
StatePublished - 1986
Externally publishedYes

Fingerprint

Calcitriol Receptors
Cholecalciferol
Hormones
DNA
Tissue
Calcifediol
Defects
Steroid Receptors
DNA-Binding Proteins
Mixed Function Oxygenases
Macromolecules
Trypsin
Primates
Haplorhini
Assays
Genes
Chemical activation
Monoclonal Antibodies
Kidney
Proteins

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Pike, J. W., Allegretto, E. A., Kelly, M. A., Donaldson, C. A., Marion, S. L., Mangelsdorf, D. J., & Haussler, M. R. (1986). 1,25-Dihydroxyvitamin D3 receptors: altered functional domains are associated with cellular resistance to vitamin D3. Advances in Experimental Medicine and Biology, 196, 377-390.

1,25-Dihydroxyvitamin D3 receptors : altered functional domains are associated with cellular resistance to vitamin D3. / Pike, J. W.; Allegretto, E. A.; Kelly, M. A.; Donaldson, C. A.; Marion, S. L.; Mangelsdorf, D. J.; Haussler, Mark R.

In: Advances in Experimental Medicine and Biology, Vol. 196, 1986, p. 377-390.

Research output: Contribution to journalArticle

Pike, J. W. ; Allegretto, E. A. ; Kelly, M. A. ; Donaldson, C. A. ; Marion, S. L. ; Mangelsdorf, D. J. ; Haussler, Mark R. / 1,25-Dihydroxyvitamin D3 receptors : altered functional domains are associated with cellular resistance to vitamin D3. In: Advances in Experimental Medicine and Biology. 1986 ; Vol. 196. pp. 377-390.
@article{483e0ec2c37d44fbbb6ef8719497c228,
title = "1,25-Dihydroxyvitamin D3 receptors: altered functional domains are associated with cellular resistance to vitamin D3.",
abstract = "1,25-Dihydroxyvitamin D3 receptors are cytosoluble proteins detectable in a variety of tissues responsive to 1,25(OH)2D3. They are DNA binding-proteins analogous to other steroid receptors and it is this functional property which is likely involved in the activation of hormone-sensitive genes. Utilizing 1,25(OH)2D3 and DNA binding assays, as well as anti-receptor monoclonal antibodies, we have probed the relationship between the 1,25(OH)2D3 receptor binding domains after selective cleavage with trypsin. These studies reveal that the hormone and DNA binding regions are separable, and are consistent with the finding that tissue resistance to 1,25(OH)2D3 is a result of structural defects in these domains. Recently, a primate model, the LLC-MK2 monkey kidney line, has been uncovered which may exemplify a hormone-binding defect. Here, 25-hydroxyvitamin D3-24-hydroxylase induction, a 1,25(OH)2D3 bioresponse, requires 100-fold higher concentrations of the hormone for maximal response. Concomitantly, this cell contains a variant receptor form which displays a correspondingly lowered apparent affinity for the hormone despite its seemingly normal DNA binding characteristics. Taken together, these studies suggest that the 1,25(OH)2D3 receptor is a macromolecule with multiple domains each of which may produce modified cellular resistance to 1,25(OH)2D3 if structurally altered.",
author = "Pike, {J. W.} and Allegretto, {E. A.} and Kelly, {M. A.} and Donaldson, {C. A.} and Marion, {S. L.} and Mangelsdorf, {D. J.} and Haussler, {Mark R}",
year = "1986",
language = "English (US)",
volume = "196",
pages = "377--390",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - 1,25-Dihydroxyvitamin D3 receptors

T2 - altered functional domains are associated with cellular resistance to vitamin D3.

AU - Pike, J. W.

AU - Allegretto, E. A.

AU - Kelly, M. A.

AU - Donaldson, C. A.

AU - Marion, S. L.

AU - Mangelsdorf, D. J.

AU - Haussler, Mark R

PY - 1986

Y1 - 1986

N2 - 1,25-Dihydroxyvitamin D3 receptors are cytosoluble proteins detectable in a variety of tissues responsive to 1,25(OH)2D3. They are DNA binding-proteins analogous to other steroid receptors and it is this functional property which is likely involved in the activation of hormone-sensitive genes. Utilizing 1,25(OH)2D3 and DNA binding assays, as well as anti-receptor monoclonal antibodies, we have probed the relationship between the 1,25(OH)2D3 receptor binding domains after selective cleavage with trypsin. These studies reveal that the hormone and DNA binding regions are separable, and are consistent with the finding that tissue resistance to 1,25(OH)2D3 is a result of structural defects in these domains. Recently, a primate model, the LLC-MK2 monkey kidney line, has been uncovered which may exemplify a hormone-binding defect. Here, 25-hydroxyvitamin D3-24-hydroxylase induction, a 1,25(OH)2D3 bioresponse, requires 100-fold higher concentrations of the hormone for maximal response. Concomitantly, this cell contains a variant receptor form which displays a correspondingly lowered apparent affinity for the hormone despite its seemingly normal DNA binding characteristics. Taken together, these studies suggest that the 1,25(OH)2D3 receptor is a macromolecule with multiple domains each of which may produce modified cellular resistance to 1,25(OH)2D3 if structurally altered.

AB - 1,25-Dihydroxyvitamin D3 receptors are cytosoluble proteins detectable in a variety of tissues responsive to 1,25(OH)2D3. They are DNA binding-proteins analogous to other steroid receptors and it is this functional property which is likely involved in the activation of hormone-sensitive genes. Utilizing 1,25(OH)2D3 and DNA binding assays, as well as anti-receptor monoclonal antibodies, we have probed the relationship between the 1,25(OH)2D3 receptor binding domains after selective cleavage with trypsin. These studies reveal that the hormone and DNA binding regions are separable, and are consistent with the finding that tissue resistance to 1,25(OH)2D3 is a result of structural defects in these domains. Recently, a primate model, the LLC-MK2 monkey kidney line, has been uncovered which may exemplify a hormone-binding defect. Here, 25-hydroxyvitamin D3-24-hydroxylase induction, a 1,25(OH)2D3 bioresponse, requires 100-fold higher concentrations of the hormone for maximal response. Concomitantly, this cell contains a variant receptor form which displays a correspondingly lowered apparent affinity for the hormone despite its seemingly normal DNA binding characteristics. Taken together, these studies suggest that the 1,25(OH)2D3 receptor is a macromolecule with multiple domains each of which may produce modified cellular resistance to 1,25(OH)2D3 if structurally altered.

UR - http://www.scopus.com/inward/record.url?scp=0022436667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022436667&partnerID=8YFLogxK

M3 - Article

C2 - 3012980

AN - SCOPUS:0022436667

VL - 196

SP - 377

EP - 390

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -